← Back
$TSHA All transactions

Taysha Gene Therapies, Inc.

A

$ Value

$0

Shares

113,246

Price

$0

Filed

Jun 4

Insider

Name

Stalfort John A III

Title

CIK

0001709418

Roles

Director

Transaction Details

Transaction Date

2025-06-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

113,246

Footnotes

Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. | The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018. | The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Filing Info

Accession No.

0001415889-25-015574

Form Type

4

Issuer CIK

0001806310

Stalfort John A III's History

Date Ticker Type Value
2025-06-04 ABOS A $0
2025-06-04 ABOS A $0
2025-06-02 TSHA A $0
2025-06-02 TSHA A $0

Other Insiders at TSHA (90d)

Insider Bought Sold Last
Nolan Sean P.
Chief Executive Officer
$840K 2026-01-26
Nagendran Sukumar
President and Head of R&D
$1.4M 2026-04-10
Alam Kamran
CHIEF FINANCIAL OFFICER
$493K 2026-02-04